Pilgrims Pride Corp: Form 10-K for the period ended Dec 25, 2022
Filed with the SEC on Feb 9, 2023 and accepted by EDGAR at Feb 9, 2023, 16:46 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-25. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-12-27 to 2022-12-25 | $17.47bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2021-12-27 to 2022-12-25 | $15.66bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2021-12-27 to 2022-12-25 | $1.81bn | us-gaap:GrossProfit |
| Research and development | 12 months2021-12-27 to 2022-12-25 | $12.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2021-12-27 to 2022-12-25 | $604.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-12-27 to 2022-12-25 | $1.18bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-12-27 to 2022-12-25 | $152.7m | us-gaap:InterestExpense |
| Income tax | 12 months2021-12-27 to 2022-12-25 | $278.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-12-27 to 2022-12-25 | $745.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-12-27 to 2022-12-25 | $3.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-12-27 to 2022-12-25 | $3.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-12-27 to 2022-12-25 | 240,394,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-12-27 to 2022-12-25 | $669.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-12-27 to 2022-12-25 | $487.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-25 | $401.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-25 | $3.89bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-25 | $9.26bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-25 | $2.57bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-25 | $6.40bn | us-gaap:Liabilities |
| Current portion of debt | At period end2022-12-25 | $26.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-12-25 | $2.84bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000802481-23-000013. Last ingested by Listed: Oct 29, 2026, 06:16 ET. Listed shows no prices and gives no investment advice.